Nanodelivery Systems Targeting Epidermal Growth Factor
10 déc. 2020 Currently neurosurgical debulking
Novel Anticancer Strategies
18 févr. 2021 epidermal growth factor receptor (EGFR)-RTK inhibitors-based nanodelivery systems [4]. Deep tumor penetration of drug-loaded nanoparticles ...
Updated Insights on EGFR Signaling Pathways in Glioma
8 janv. 2021 epidermal growth factor receptor (EGFR) amplification is a characteristic of the classical subtype of glioma. However targeted therapies ...
Nanodelivery Systems Targeting Epidermal Growth Factor
Factor Receptors for Glioma Management nanodelivery systems. Keywords: glioblastoma; receptor tyrosine kinases; epidermal growth factor receptor; ...
Nanodelivery Systems Targeting Epidermal Growth Factor
Lapatinib nano-delivery systems: a promising future for breast
5 mars 2018 delivery systems for administration through non-oral routes ... Epidermal Growth Factor Receptor (EGFR) and HER2 [22-24].
Glioblastoma pharmacotherapy: A multifaceted perspective of
21 sept. 2021 Abbreviations: PDGFR platelet‑derived growth factor receptor; ... Key words: glioblastoma
Therapeutic strategies of recurrent glioblastoma and its molecular
22 janv. 2021 mainly from the regrowth of malignant cells after eradicating specific clones by targeted treatment. Epidermal growth factor receptor ...
Challenges of Current Anticancer Treatment Approaches with Focus
24 août 2021 ambaram S.B.; Gowda
Updated Insights on EGFR Signaling Pathways in Glioma
8 janv. 2021 known that epidermal growth factor receptor (EGFR) amplification is a characteristic of the classi- cal subtype of glioma. However targeted ...